Evaluation of fulvestrant (F) activity and toxicity in heavily pretreated patients with advanced breast cancer (ABC)

被引：0
|
作者：
Catania, C. [1 ]
Ascione, G. [1 ]
Medici, M. [1 ]
Verri, E. [1 ]
Sanna, G. [1 ]
Marenghi, C. [1 ]
Minchella, I. [1 ]
Adamoli, L. [1 ]
Goldhirsch, A. [1 ]
Nole, F. [1 ]
机构：
[1] European Inst Oncol, Dept Med, Med Care Unit, Milan, Italy
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：126 / 126
页数：1
相关论文
共 50 条
  • [1] Fulvestrant in heavily pretreated postmenopausal women with advanced breast cancer
    Martinez Marin, Virginia
    Munoz Martin, Andres J.
    Vinuela Beneitez, M. Carmen
    Garcia Alfonso, Pilar
    Alonso Munoz, Antonio
    Perez Manga, Gumersindo
    MEDICINA CLINICA, 2009, 133 (10): : 371 - 374
  • [2] Fulvestrant in heavily pretreated patients with advanced breast cancer: A Belgium cooperative study.
    Neven, P.
    Paridaens, R.
    Pelgrims, G.
    Martens, M.
    Bols, A.
    Goeminne, J. C.
    Vindevoghel, A.
    Demol, J.
    Stragier, B.
    De Greve, J.
    Schallier, D.
    Van Den Weyngaert, D.
    Becquart, D.
    Borms, M.
    Cocquyt, V
    Van Den Broecke, R.
    Selleslags, J.
    Awada, A.
    Dirix, L.
    Van Dam, P.
    Azerad, M. A.
    Vandenhoven, G.
    Christianes, M. R.
    Vergote, I
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S195 - S195
  • [3] Clinical benefit of fulvestrant in heavily pretreated patients with metastatic breast cancer
    Scandurra, Giuseppa
    Carillio, Guido
    Aiello, Rosa Anna
    Chiarenza, Maurizio
    Mazzola, Antonella
    Ali, Marco
    Barone, Gloria
    Greco, Filippo
    Caruso, Michele
    ANNALS OF ONCOLOGY, 2007, 18 : 44 - 44
  • [4] Fulvestrant in heavily pretreated patients with advanced breast cancer:: experience from a Named Patient Programme in Switzerland
    Hawle, H.
    Thuerlimann, B.
    Pagani, O.
    Buser, K.
    Bonnefoi, H.
    Forni, M.
    Aapro, M.
    Mach, N.
    EJC SUPPLEMENTS, 2005, 3 (02): : 125 - 125
  • [5] Efficacy of Fulvestrant in Heavily Pretreated Postmenopausal Women with Advanced Breast Cancer: A Preliminary Report
    Yoo, Changhoon
    Kim, Sung-Bae
    Ahn, Jin-Hee
    Jung, Kyung Hae
    Ahn, Yongchel
    Gong, Gyungyub
    Kim, Hak-Hee
    Kim, Hee-Jung
    Sun, Byung-Ho
    Alm, Sei-Hyun
    JOURNAL OF BREAST CANCER, 2011, 14 (02) : 135 - 139
  • [6] Docetaxel (DT) in anthracycline-pretreated advanced breast cancer (ABC): Toxicity and activity
    Ferraresi, V
    Vaccaro, A
    Milella, M
    D'Ottavio, AM
    Papaldo, P
    Nistico, C
    Thorel, MF
    Marsella, A
    Terzoli, E
    Cognetti, F
    ANNALS OF ONCOLOGY, 1998, 9 : 19 - 19
  • [7] Fulvestrant in heavily pretreated metastatic breast cancer: Is it still effective as a very advanced line of treatment?
    Safra, Tamar
    Greenberg, Julia
    Ron, Ilan G.
    Ben-Yosef, Rami
    Inbar, Moshe
    Sarid, David
    Yaal-Hahoshen, Neora
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2008, 10 (05): : 339 - 343
  • [8] Trastuzumab (T) plus capecitabine (C) in heavily pretreated patients (pts) with advanced breast cancer (ABC)
    Bartsch, R.
    Wenzel, C.
    Altorjai, G.
    Pluschnig, U.
    Locker, G. J.
    Rudas, M.
    Mader, R. M.
    Zielinski, C. C.
    Steger, G. G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] Clinical experience with fulvestrant in pretreated patients with advanced breast cancer.
    Menjon Beltran, S.
    Garcia Garcia, J., Sr.
    Gonzalez Flores, E.
    Conde Herrero, V.
    Gonzalez Jimenez, E., Sr.
    Gutierrez Lomas, V., Sr.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [10] Fulvestrant: a new opportunity in advanced breast cancer (ABC)
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 170 - 170
12345